content top

Quality of Life in Patients with Age-related Macular Degeneration: Results from the VI.S.I.O.N. Trial

Manjula Patel, MD (New York, NY),* Jordi Mones, MD (Barcelona, Spain), Anita Leys, PhD, MD (Leuven, Belgium), Gergana Zlateva, PhD (New York, NY),* Sonali N. Shah, BS Pharm, MPH (New York, NY)* PURPOSE: Patients with AMD are more likely to need help with daily activities, experience more emotional distress, and report a reduced quality of life than those without AMD. Pegaptanib sodium is the first pharmacological treatment for subfoveal...

Read More

Comparison of Comorbid Conditions Between Wet AMD Patients and a Control Cohort in the Medicare Population

http://www.evrs.eu/medias/2006/congress/Comparison-of-Comorbid-Conditions-Between-Wet-AMD-Patients-and-a-Control-Cohort-in-the-Medicare-Population.swf Gergana Zlateva, PhD (New York, NY),* Emmett T. Cunningham, MD, PhD, MPH (South San Francisco, CA), Jonathan C. Javitt, MD, MPH (Washington, DC),* Steve Zhou, PhD (Bridgewater, NJ),* Sonali N. Shah, BS, MPH (New York, NY)* PURPOSE: In addition to the burden imposed by vision loss, elderly AMD...

Read More

Humanistic Burden and Health Resource Utilization in Neovascular Age-related Macular Degeneration (AMD) Patients from Five Countries

http://www.evrs.eu/medias/2006/congress/Humanistic-Burden-and-Health-Resource-Utilization-in-Neovascular-Age-related-Macular-Degeneration-(AMD)-Patients-from-Five-Countries.swf Gisele Soubrane, MD (Creteil, France), Daniel Pauleikhoff, Prof. Dr. med. (Munster, Germany), Alan F. Cruess, MD FRCSC (Halifax, Canada), Andrew Lotery, MD FRCOphth (Southampton, UK),* Jordi Monès, MD (Barcelona, Spain), Xiao Xu, PhD, RN (Gaithersberg, MD),* Gergana...

Read More
content top